The liver is a vital organ involved in hundreds of body functions
[VERIFY: Confirm current FDA/compounding regulatory status of IGF-1 LR3 with healthcare attorney before publishing
Bimagrumab (the heavy hand) Rather than targeting myostatin specifically, bimagrumab blocks the activin type II receptor (ActRII) a broader docking port that myostatin and several related proteins all use
Its lower concentration is associated with the development of IR and T2DM [39]
Further, higher baseline BMI and A1C may suggest that lower income individuals wait longer to add second line therapies, like GLP-1 RAs, potentially due to the high cost relative to first line therapies (such as metformin)
At Revolution Health & Wellness , we guide patients through the AIP protocol with tailored meal planning, supplement support, peptide therapy, and lab testing to track results